Scarica l'app Stockscreener
44.03
3.49%
-1.59
Dopo l'orario di chiusura:
44.00
-0.03
-0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AKRO Giù?
Forum
Previsione
Precedente Chiudi:
$45.62
Aprire:
$46.18
Volume 24 ore:
1.34M
Relative Volume:
1.08
Capitalizzazione di mercato:
$3.52B
Reddito:
-
Utile/perdita netta:
$-269.44M
Rapporto P/E:
-11.74
EPS:
-3.75
Flusso di cassa netto:
$-262.63M
1 W Prestazione:
-6.20%
1M Prestazione:
-9.44%
6M Prestazione:
-1.12%
1 anno Prestazione:
+67.41%
Intervallo 1D:
$43.08
$46.18
Intervallo di 1 settimana:
$43.08
$47.67
Portata 52W:
$21.34
$58.40
Akero Therapeutics Inc Stock (AKRO) Company Profile
Nome
Akero Therapeutics Inc
Settore
Industria
Telefono
650-487-6488
Indirizzo
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
Confronta AKRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AKRO
Akero Therapeutics Inc
|
44.03 | 3.63B | 0 | -269.44M | -262.63M | -3.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-04 | Iniziato | TD Cowen | Buy |
| 2025-01-30 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-01-27 | Reiterato | H.C. Wainwright | Buy |
| 2024-11-18 | Iniziato | Citigroup | Buy |
| 2024-04-22 | Ripresa | BofA Securities | Neutral |
| 2023-09-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-08-28 | Iniziato | UBS | Buy |
| 2023-01-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-14 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-10-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-10 | Iniziato | BofA Securities | Buy |
| 2021-02-26 | Iniziato | Guggenheim | Buy |
| 2020-09-10 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-20 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-07 | Iniziato | Chardan Capital Markets | Buy |
| 2020-07-01 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-02 | Iniziato | H.C. Wainwright | Buy |
| 2020-02-10 | Iniziato | Canaccord Genuity | Buy |
| 2019-07-15 | Iniziato | Evercore ISI | Outperform |
| 2019-07-15 | Iniziato | JP Morgan | Overweight |
| 2019-07-15 | Iniziato | Jefferies | Buy |
| 2019-07-15 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Akero Therapeutics Inc Borsa (AKRO) Ultime notizie
Key resistance and support levels for Akero Therapeutics Inc.Weekly Investment Summary & AI Optimized Trade Strategies - Newser
Akero Therapeutics Inc. stock daily chart insights2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - Newser
Will Akero Therapeutics Inc. continue its uptrendForecast Cut & Capital Efficient Trade Techniques - Newser
Akero Therapeutics Inc. recovery potential after sell off2025 Fundamental Recap & Weekly High Return Forecasts - Newser
Using flow based indicators on Akero Therapeutics Inc.2025 Market Overview & Smart Allocation Stock Reports - Newser
Can Akero Therapeutics Inc. deliver alphaJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - khodrobank.com
Intraday pattern recognizer results for Akero Therapeutics Inc.Rate Hike & AI Enhanced Trading Alerts - Newser
Walleye Capital LLC Decreases Stock Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Given Average Rating of "Buy" by Analysts - MarketBeat
Published on: 2025-09-03 02:35:46 - Newser
Chart overlay techniques for tracking Akero Therapeutics Inc.Quarterly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
How to interpret RSI for Akero Therapeutics Inc. stockEarnings Risk Report & AI Enhanced Trading Alerts - Newser
Market reaction to Akero Therapeutics Inc.’s recent newsEarnings Overview Summary & Weekly Breakout Stock Alerts - Newser
What MACD and RSI say about Akero Therapeutics Inc.Weekly Trade Summary & Growth Oriented Trading Recommendations - Newser
How cyclical is Akero Therapeutics Inc.’s revenue streamVolume Spike & Free Technical Pattern Based Buy Signals - khodrobank.com
Is Akero Therapeutics Inc. forming a reversal pattern2025 Support & Resistance & Fast Gain Swing Alerts - Newser
Will Akero Therapeutics Inc. price bounce be sustainable2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser
How does Akero Therapeutics Inc. compare to its peersJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - khodrobank.com
Tema Etfs LLC Lowers Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Exit strategy if you’re trapped in Akero Therapeutics Inc.Quarterly Earnings Summary & Free Weekly Watchlist of Top Performers - Newser
How does Akero Therapeutics Inc. score in quality rankingsProfit Target & Expert Approved Momentum Trade Ideas - khodrobank.com
FORA Capital LLC Acquires Shares of 16,473 Akero Therapeutics, Inc. $AKRO - MarketBeat
Propel Bio Management LLC Sells 114,845 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Smart tools for monitoring Akero Therapeutics Inc.’s price action2025 Geopolitical Influence & Growth Focused Entry Reports - Newser
Can Akero Therapeutics Inc. rally from current levelsTrade Signal Summary & Long-Term Safe Investment Plans - Newser
Candlestick signals on Akero Therapeutics Inc. stock today2025 Valuation Update & Safe Capital Growth Stock Tips - Newser
Northern Trust Corp Buys 36,412 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Aug Gainers: What’s Akero Therapeutics Inc.’s historical returnQuarterly Investment Review & Low Risk High Win Rate Stock Picks - khodrobank.com
Candlestick Reversal Detected on Akero Therapeutics Inc.’s ChartLayoff News & Accurate Technical Buy Alerts - beatles.ru
What’s Akero Therapeutics Inc.’s historical returnPortfolio Gains Report & Weekly Hot Stock Watchlists - khodrobank.com
Aug Rallies: Will Akero Therapeutics Inc. benefit from rising consumer demandTrade Exit Report & Low Risk Entry Point Tips - khodrobank.com
Akero Therapeutics Inc. Stages Intraday Comeback — Trend ChangeQuarterly Trade Report & Low Risk High Reward Ideas - beatles.ru
Will Akero Therapeutics Inc. benefit from rising consumer demand2025 Market WrapUp & Weekly Top Gainers Trade List - khodrobank.com
Invesco Ltd. Raises Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Live market analysis of Akero Therapeutics Inc.July 2025 Spike Watch & High Yield Stock Recommendations - Newser
Using AI based signals to follow Akero Therapeutics Inc.2025 Analyst Calls & Momentum Based Trading Signals - Newser
Long Focus Capital Management LLC Purchases 9,900 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics Inc.’s volatility index tracking explainedForecast Cut & Weekly Consistent Profit Watchlists - Newser
Best data tools to analyze Akero Therapeutics Inc. stock2025 Support & Resistance & Free Safe Capital Growth Stock Tips - Newser
Should you wait for a breakout in Akero Therapeutics Inc.Market Performance Recap & Breakout Confirmation Alerts - Newser
Risk adjusted return profile for Akero Therapeutics Inc. analyzedGap Up & High Yield Stock Recommendations - Newser
Can trapped investors hope for a rebound in Akero Therapeutics Inc.2025 Momentum Check & Low Risk High Win Rate Picks - Newser
How to build a dashboard for Akero Therapeutics Inc. stock2025 Big Picture & Entry Point Confirmation Signals - Newser
Regression analysis insights on Akero Therapeutics Inc. performanceQuarterly Market Summary & Verified Swing Trading Watchlist - Newser
Akero Therapeutics Inc Azioni (AKRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Akero Therapeutics Inc Azioni (AKRO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Young Jonathan | Chief Operating Officer |
Aug 12 '25 |
Option Exercise |
21.10 |
12,500 |
263,750 |
209,984 |
| Young Jonathan | Chief Operating Officer |
Aug 12 '25 |
Sale |
47.79 |
12,500 |
597,326 |
197,484 |
| Cheng Andrew | President and CEO |
Aug 11 '25 |
Sale |
48.59 |
30,000 |
1,457,596 |
490,757 |
| Henderson Jane | Director |
Aug 12 '25 |
Option Exercise |
7.01 |
3,000 |
21,027 |
12,398 |
| Henderson Jane | Director |
Aug 12 '25 |
Sale |
47.46 |
3,000 |
142,371 |
9,398 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):